Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids
Cells · 13.07.2024 · 13 (14) · 1190
DOI: 10.3390/cells13141190 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 13.07.2024. Verfasst von Do Hyun Na und 8 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: Organoids, Induced Pluripotent Stem Cells, Kidney Diseases, Kidney. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Research Fund of Seoul St. Mary’s Hospital, The catholic University of Korea.
Abstract (Originalsprache)
Genetic or hereditary kidney disease stands as a pivotal cause of chronic kidney disease (CKD). The proliferation and widespread utilization of DNA testing in clinical settings have notably eased the diagnosis of genetic kidney diseases, which were once elusive but are now increasingly identified in cases previously deemed CKD of unknown etiology. However, despite these diagnostic strides, research into disease pathogenesis and novel drug development faces significant hurdles, chiefly due to the dearth of appropriate animal models and the challenges posed by limited patient cohorts in clinical studies. Conversely, the advent and utilization of human-induced pluripotent stem cells (hiPSCs) offer a promising avenue for genetic kidney disease research. Particularly, the development of hiPSC-derived kidney organoid systems presents a novel platform for investigating various forms of genetic kidney diseases. Moreover, the integration of the CRISPR/Cas9 technique into this system holds immense potential for efficient research on genetic kidney diseases. This review aims to explore the applications of in vitro kidney organoids generated from hiPSCs in the study of diverse genetic kidney diseases. Additionally, it will delve into the limitations of this research platform and outline future perspectives for advancing research in this crucial area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Transplantation Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Division of Nephrology, Department of Internal Medicine, Incheon St. Mary's Hospital, The College of Medicine, The Catholic University of Korea, Incheon 21431, Republic of Korea.
ORCID-Profile: Do Hyun Na, Sheng Cui, Yoo Jin Shin, Sun Woo Lim, Chul Woo Yang, Byung Ha Chung
Förderung
- National Research Foundation of Korea (NRF)
- Research Fund of Seoul St. Mary’s Hospital, The catholic University of Korea
Zitieren
APA
Na, D. H., Cui, S., Fang, X., Lee, H., Eum, S. H., Shin, Y. J., Lim, S. W., Yang, C. W., & Chung, B. H. (2024). Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids. Cells, 13(14), 1190. https://doi.org/10.3390/cells13141190
Vancouver
Na DH, Cui S, Fang X, Lee H, Eum SH, Shin YJ, et al. Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids. Cells. 2024;13(14):1190. doi:10.3390/cells13141190
BibTeX
@article{Na2024,
author = {Na, Do Hyun and Cui, Sheng and Fang, Xianying and Lee, Hanbi and Eum, Sang Hun and Shin, Yoo Jin and Lim, Sun Woo and Yang, Chul Woo and Chung, Byung Ha},
title = {Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids},
journal = {Cells},
year = {2024},
volume = {13},
number = {14},
pages = {1190},
doi = {10.3390/cells13141190}
}
EUVIMED